Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cass

Showing results (31-40 of 178) with videos related to

Pageof 18
Sort By:
Journal of Neurochemistry|July 1, 1991
Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine releaseW A Cass, N R Zahniser
The Journal of Urology|November 1, 1972
Comparison of ileac and colonic conduit urinary diversions in dogsB Spence, J Esho, A Cass
Neurochemical Research|February 2, 2010
Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNFWayne A Cass, Laura E Peters
Internal Medicine Journal|May 21, 2004
Renal-related deaths in Australia 1997-1999S Q Li, J Cunningham, A Cass
Emerging Topics in Life Sciences|November 1, 2021
Targetable nano-delivery vehicles to deliver anti-bacterial small acid-soluble spore protein (SASP) genesAnne M L Barnard, James A Cass
The Medical Journal of Australia|December 11, 1999
Australians with renal disease: a new national surveyA Cass, S P McDonald, Z Wang
Experimental Neurology|March 3, 2006
Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatumShaji Theodore, Wayne A Cass, William F Maragos
Urology|December 1, 1979
Necrotizing infection of scrotumM Biswas, C Godec, G Ireland, et al.
Plant Physiology|November 1, 1983
In situ field measurement of leaf water potential using thermocouple psychrometersM J Savage, H H Wiebe, A Cass
Neuroscience|December 13, 2005
Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatumS Theodore, W A Cass, W F Maragos
Pageof 18

Showing results (31-40 of 178) with videos related to

Sort By:
Pageof 18
Journal of Neurochemistry|July 1, 1991
Potassium channel blockers inhibit D2 dopamine, but not A1 adenosine, receptor-mediated inhibition of striatal dopamine releaseW A Cass, N R Zahniser
The Journal of Urology|November 1, 1972
Comparison of ileac and colonic conduit urinary diversions in dogsB Spence, J Esho, A Cass
Neurochemical Research|February 2, 2010
Neurturin effects on nigrostriatal dopamine release and content: comparison with GDNFWayne A Cass, Laura E Peters
Internal Medicine Journal|May 21, 2004
Renal-related deaths in Australia 1997-1999S Q Li, J Cunningham, A Cass
Emerging Topics in Life Sciences|November 1, 2021
Targetable nano-delivery vehicles to deliver anti-bacterial small acid-soluble spore protein (SASP) genesAnne M L Barnard, James A Cass
The Medical Journal of Australia|December 11, 1999
Australians with renal disease: a new national surveyA Cass, S P McDonald, Z Wang
Experimental Neurology|March 3, 2006
Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatumShaji Theodore, Wayne A Cass, William F Maragos
Urology|December 1, 1979
Necrotizing infection of scrotumM Biswas, C Godec, G Ireland, et al.
Plant Physiology|November 1, 1983
In situ field measurement of leaf water potential using thermocouple psychrometersM J Savage, H H Wiebe, A Cass
Neuroscience|December 13, 2005
Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatumS Theodore, W A Cass, W F Maragos
Pageof 18